Season's Savings | ₹5/mo for 3 months
₹199/month after first 3 months. Renews automatically. Terms apply.
ICT Ep 2.42: Robert Goldman on Rethinking Feasibility (Part 2/3)
Failed to add items
Add to cart failed.
Add to wishlist failed.
Remove from wishlist failed.
Follow podcast failed
Unfollow podcast failed
ICT Ep 2.42: Robert Goldman on Rethinking Feasibility (Part 2/3)
-
Narrated by:
-
Written by:
In Part 2 of this three-part conversation, Liam and Ted continue their discussion with Robert Goldman, Vice President and Global Head of Clinical Operations at Contraline, to talk about why feasibility so often fails to predict what happens next.
Robert explains why historical benchmarks mean little for a study that has never been done, and what he would use instead: measurable assumptions, early performance indicators, and intervention points agreed in advance. Ted raises the feasibility question he has never seen on a questionnaire, and Robert explains why sites are afraid to answer it honestly. They discuss why sponsors budget for backup sites, why the fastest responders aren’t always the best, and how sponsors can build real relationships with sites before the selection process begins.
Join us in Part 3 of the conversation as Robert gives his take on AI in clinical operations.